---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-015876"
form_type: "8-K"
ticker: "STXS"
cik: "0001289340"
company_name: "Stereotaxis, Inc."
filed_at: "2023-05-09T23:59:59+00:00"
generated_at: "2026-06-15T08:25:13.880847+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Stereotaxis Q1 revenue $6.5M, net loss $5.3M; reiterates double-digit growth outlook

## Summary
- Revenue $6.5M vs $7.0M prior year; excluding catheter royalties, essentially flat.
- Net loss $5.3M vs $4.1M; adjusted net loss (excl stock comp) $2.7M vs $1.6M.
- Gross margin 59%; recurring revenue gross margin 79%, system margin 7% on low volumes.
- Cash $26.8M with no debt; year-end cash expected $22-24M; sees double-digit revenue growth in 2023.
- Orders received for two Genesis systems; expects increase in system orders vs 2022.

## SEC filing metadata
- accession: 0001493152-23-015876
- form_type: 8-K
- ticker: STXS
- cik: 0001289340
- company_name: Stereotaxis, Inc.
- filed_at: 2023-05-09T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1289340/000149315223015876/0001493152-23-015876-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1289340/000149315223015876/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-015876
- JSON: https://secwatch.observer/filing/0001493152-23-015876.json
- Plain text: https://secwatch.observer/filing/0001493152-23-015876.txt

## Key facts
- Earnings Releases
  Stereotaxis, Inc. reported the first quarter ended March 31, 2023 results: revenue $6.5 million, net income ($5.3) million. Guidance reaffirmed.
  - Period: the first quarter ended March 31, 2023
  - Revenue: $6.5 million
  - Net income: ($5.3) million
  - Guidance: reaffirmed
  - Result: reported results
  source text: on May 19-21 and sharing meaningful updates on our innovation strategy at the conference.” 2023 First Quarter Financial Results Revenue for the first quarter of 2023 totaled $6.5 million compared to $7.0 million in the prior year first quarter. Revenue in these quarters were equivalent excluding catheter royalties received in the prior year. System revenue for
  evidence_url: https://www.sec.gov/Archives/edgar/data/1289340/000149315223015876/0001493152-23-015876-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.